Sally Gaffigan

Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL): initial phase I/II study results.

D. Fisher, O. Press, P. Weiden, 2000, Cancer biotherapy & radiopharmaceuticals.

Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer.

M. Goris, M. Tempero, G. Adams, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase II Trial of Yttrium-90-DOTA-Biotin Pretargeted by NR-LU-10 Antibody / Streptavidin in Patients with Metastatic Colon Cancer 1

M. Goris, M. Tempero, G. Adams, 2000 .